← Back to headlines
Mainz Biomed Secures $6 Million Private Placement, Focuses on Pancreatic Cancer
Mainz Biomed has secured a $6 million private placement and is shifting its focus to a U.S. pancreatic cancer program.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
